975465

Acorda Therapeutics, Inc. — FEI 3002457563

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pearl River, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
672821 CFR 314.80(b)Failure to review ADE information